力生制药：关于公司高级管理人员减持股份预披露公告

Core Points - The company, Lisheng Pharmaceutical, announced that senior management personnel, Guo Xiaoyan, plans to reduce her holdings in the company by selling up to 11,200 shares within three months after a 15 trading day period from the announcement date [2] Summary by Category Company Announcement - Guo Xiaoyan holds 114,800 shares, representing 0.0446% of the company's total share capital and 0.0448% of the total share capital excluding shares in the repurchase account [2] - The planned reduction in shareholding will not exceed 0.0044% of the total share capital after excluding shares in the repurchase account [2]